The Global Meningococcal Initiative: Recommendations for Reducing the Global Burden of Meningococcal Disease
The Global Meningococcal Initiative (GMI) is composed of an international group of scientists, clinicians, and public health officials that aim to promote the global prevention of invasive meningococcal disease through education and research. In this article, published in Vaccine, the GMI members review global meningococcal disease epidemiology, immunization strategies, and research needs, and make recommendations for reducing the burden of disease worldwide. These include strengthening disease surveillance efforts, increasing research on vaccine effectiveness and impact, and improving country-specific meningococcal vaccination policies. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)
Author(s): Harrison LH, Pelton SI, Wilder-Smith A, et al.
Visit web page (English)
(Located at www.sciencedirect.com)
Citation: Harrison LH, Pelton SI, Wilder-Smith A, et al. The Global Meningococcal Initiative: Recommendations for Reducing the Global Burden of Meningococcal Disease. Vaccine. 2011;29(18):3363–3371.